RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Hamden, CT · New Haven, CT · +85 more sites
6 recruiting crohn's disease studies with a site in New Haven, CT.
Sponsor: Merck Sharp & Dohme LLC
Hamden, CT · New Haven, CT · +85 more sites
Sponsor: National Cancer Institute (NCI)
New Haven, CT · +49 more sites
Sponsor: AbbVie
Danbury, CT · New Haven, CT · +62 more sites
Sponsor: Sanofi
New Haven, CT · +124 more sites
Sponsor: Mayo Clinic
New Haven, CT · +23 more sites
Sponsor: University of North Carolina, Chapel Hill
New Haven, CT · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.